Patients with Crohn's disease on anti-tumor necrosis factor therapy are at significant risk of inadequate response to the 23-valent pneumococcal polysaccharide vaccine.
Lee CK, Kim HS, Ye BD, Lee KM, Kim YS, Rhee SY, Kim HJ, Yang SK, Moon W, Koo JS, Lee SH, Seo GS, Park SJ, Choi CH, Jung SA, Hong SN, Im JP, Kim ES; Korean Association for the Study of Intestinal Diseases (KASID) Study.
Lee CK, et al. Among authors: hong sn.
J Crohns Colitis. 2014 May;8(5):384-91. doi: 10.1016/j.crohns.2013.09.022. Epub 2013 Oct 19.
J Crohns Colitis. 2014.
PMID: 24144611